CVE-2018-9163

Public Exploit

Description

A stored Cross-site scripting (XSS) vulnerability in Zoho ManageEngine Recovery Manager Plus before 5.3 (Build 5350) allows remote authenticated users (with Add New Technician permissions) to inject arbitrary web script or HTML via the loginName field to technicianAction.do.

Category

5.4
CVSS
Severity: Medium
CVSS 3.0 •
CVSS 2.0 •
EPSS 2.44% Top 20%
Third-Party Advisory securityfocus.com Third-Party Advisory gurelahmet.com Third-Party Advisory exploit-db.com
Affected: n/a n/a
Published at:
Updated at:

References

Link Tags
https://www.manageengine.com/ad-recovery-manager/release-notes.html#5350 release notes
https://gurelahmet.com/cve-2018-9163-zoho-manageengine-recovery-manager-plus-5-3-build-5330-stored-cross-site-scripting-xss-vulnerability/ third party advisory exploit
http://www.securityfocus.com/bid/103773 vdb entry third party advisory
https://www.exploit-db.com/exploits/44666/ exploit vdb entry third party advisory

Frequently Asked Questions

What is the severity of CVE-2018-9163?
CVE-2018-9163 has been scored as a medium severity vulnerability.
How to fix CVE-2018-9163?
To fix CVE-2018-9163, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2018-9163 being actively exploited in the wild?
It is possible that CVE-2018-9163 is being exploited or will be exploited in a near future based on public information. According to its EPSS score, there is a ~2% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.